Ken Griffin Stereotaxis, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,800 shares of STXS stock, worth $4,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,800
Previous 11,200
83.93%
Holding current value
$4,014
Previous $20,000
85.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding STXS
# of Institutions
89Shares Held
41.1MCall Options Held
139KPut Options Held
20.6K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$30.5 Million7.17% of portfolio
-
Lagoda Investment Management, L.P. New York, NY3.83MShares$8.54 Million4.5% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$7.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$6.9 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.79MShares$6.22 Million6.12% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $167M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...